These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. Dickson DW; Wertkin A; Kress Y; Ksiezak-Reding H; Yen SH Lab Invest; 1990 Jul; 63(1):87-99. PubMed ID: 2165197 [TBL] [Abstract][Full Text] [Related]
3. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome. Ikeda S; Allsop D; Glenner GG Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370 [TBL] [Abstract][Full Text] [Related]
4. Ubiquitin immunoelectron microscopy of dystrophic neurites in cerebellar senile plaques of Alzheimer's disease. Dickson DW; Wertkin A; Mattiace LA; Fier E; Kress Y; Davies P; Yen SH Acta Neuropathol; 1990; 79(5):486-93. PubMed ID: 2158201 [TBL] [Abstract][Full Text] [Related]
6. The developmental and aging changes of Down's syndrome cell adhesion molecule expression in normal and Down's syndrome brains. Saito Y; Oka A; Mizuguchi M; Motonaga K; Mori Y; Becker LE; Arima K; Miyauchi J; Takashima S Acta Neuropathol; 2000 Dec; 100(6):654-64. PubMed ID: 11078217 [TBL] [Abstract][Full Text] [Related]
7. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882 [TBL] [Abstract][Full Text] [Related]
8. The cortical neuritic pathology of Huntington's disease. Jackson M; Gentleman S; Lennox G; Ward L; Gray T; Randall K; Morrell K; Lowe J Neuropathol Appl Neurobiol; 1995 Feb; 21(1):18-26. PubMed ID: 7770116 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Lippa CF; Schmidt ML; Lee VM; Trojanowski JQ Ann Neurol; 1999 Mar; 45(3):353-7. PubMed ID: 10072050 [TBL] [Abstract][Full Text] [Related]
11. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117 [TBL] [Abstract][Full Text] [Related]
12. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis. Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042 [TBL] [Abstract][Full Text] [Related]
13. Down's syndrome in middle age. Topographical distribution and immunoreactivity of brain lesions in an autopsied patient. Yoshimura N; Kubota S; Fukushima Y; Kudo H; Ishigaki H; Yoshida Y Acta Pathol Jpn; 1990 Oct; 40(10):735-43. PubMed ID: 1963256 [TBL] [Abstract][Full Text] [Related]
14. Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Teller JK; Russo C; DeBusk LM; Angelini G; Zaccheo D; Dagna-Bricarelli F; Scartezzini P; Bertolini S; Mann DM; Tabaton M; Gambetti P Nat Med; 1996 Jan; 2(1):93-5. PubMed ID: 8564851 [TBL] [Abstract][Full Text] [Related]
15. Developmental immunohistochemistry of growth inhibitory factor in normal brains and brains of patients with Down syndrome. Arai Y; Uchida Y; Takashima S Pediatr Neurol; 1997 Sep; 17(2):134-8. PubMed ID: 9367293 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of s100beta in Down's syndrome: correlation with patient age and with beta-amyloid deposition. Royston MC; McKenzie JE; Gentleman SM; Sheng JG; Mann DM; Griffin WS; Mrak RE Neuropathol Appl Neurobiol; 1999 Oct; 25(5):387-93. PubMed ID: 10564528 [TBL] [Abstract][Full Text] [Related]
17. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Cras P; Kawai M; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7552-6. PubMed ID: 1652752 [TBL] [Abstract][Full Text] [Related]
18. Colocalization of lysosomal hydrolase and beta-amyloid in diffuse plaques of the cerebellum and striatum in Alzheimer's disease and Down's syndrome. Cataldo AM; Barnett JL; Mann DM; Nixon RA J Neuropathol Exp Neurol; 1996 Jun; 55(6):704-15. PubMed ID: 8642396 [TBL] [Abstract][Full Text] [Related]
19. HB-GAM is a cytokine present in Alzheimer's and Down's syndrome lesions. Wisniewski T; Lalowski M; Baumann M; Rauvala H; Raulo E; Nolo R; Frangione B Neuroreport; 1996 Jan; 7(2):667-71. PubMed ID: 8730853 [TBL] [Abstract][Full Text] [Related]